Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2023-08-22 00:00:00 ET · period of report 2023-08-18 · accession 0001787306-23-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-22 | 2023-08-21 | ARQT | Burnett Patrick | See Remarks | S - Sale | $7.04 | -1,605 | 58.4K | -3% | -$11.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-21 | S | D | 300 | $7.05 | 59,662 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-21 | S | D | 1,305 | $7.04 | 58,357 | D | — | — |